These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 35075971)
1. Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study. Camus V; Viennot M; Lévêque E; Viailly PJ; Tonnelet D; Veresezan EL; Drieux F; Etancelin P; Dubois S; Stamatoullas A; Tilly H; Bohers E; Jardin F Leuk Lymphoma; 2022 Apr; 63(4):834-844. PubMed ID: 35075971 [TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453 [TBL] [Abstract][Full Text] [Related]
3. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma. Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256 [TBL] [Abstract][Full Text] [Related]
4. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma. Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666 [TBL] [Abstract][Full Text] [Related]
6. Clinical Features and Therapeutic Outcomes Comparing Primary Mediastinal Large B-cell Lymphoma to Mediastinal Hodgkin Disease. Cruz-Chamorro RJ; Rodríguez-López JL; González-Soto MJ; Arroyo-Suárez R; Ortiz-Sánchez C; Encarnación-Medina J; Cabanillas F P R Health Sci J; 2024 Jun; 43(2):79-83. PubMed ID: 38860961 [TBL] [Abstract][Full Text] [Related]
7. Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas. Singh K; Lezama LS; Kurzer J; Oak J; Schultz LM; Walkush A; Cheng TC; Chen EH; May WA; Chang C; Link MP; Advani RH; Suarez CJ; Natkunam Y Am J Surg Pathol; 2023 Jan; 47(1):81-90. PubMed ID: 36001451 [TBL] [Abstract][Full Text] [Related]
8. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E Virchows Arch; 2023 Dec; 483(6):733-749. PubMed ID: 37530791 [TBL] [Abstract][Full Text] [Related]
9. Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. Pittaluga S; Nicolae A; Wright GW; Melani C; Roschewski M; Steinberg S; Huang D; Staudt LM; Jaffe ES; Wilson WH Blood Cancer Discov; 2020 Sep; 1(2):155-161. PubMed ID: 32914098 [TBL] [Abstract][Full Text] [Related]
10. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting. Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315 [TBL] [Abstract][Full Text] [Related]
12. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas. Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470 [TBL] [Abstract][Full Text] [Related]
13. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma. Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043 [TBL] [Abstract][Full Text] [Related]
14. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling. Yuan J; Wright G; Rosenwald A; Steidl C; Gascoyne RD; Connors JM; Mottok A; Weisenburger DD; Greiner TC; Fu K; Smith L; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Ott G; Vose JM; Staudt LM; Chan WC; Am J Surg Pathol; 2015 Oct; 39(10):1322-30. PubMed ID: 26135560 [TBL] [Abstract][Full Text] [Related]
15. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Moore EM; Swerdlow SH; Gibson SE Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661 [TBL] [Abstract][Full Text] [Related]
16. Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Grant C; Dunleavy K; Eberle FC; Pittaluga S; Wilson WH; Jaffe ES Curr Hematol Malig Rep; 2011 Sep; 6(3):157-63. PubMed ID: 21590365 [TBL] [Abstract][Full Text] [Related]
18. A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma. Durand M; Cabaud Gibouin V; Duplomb L; Salmi L; Caillot M; Sola B; Camus V; Jardin F; Garrido C; Jego G J Exp Clin Cancer Res; 2024 May; 43(1):148. PubMed ID: 38773631 [TBL] [Abstract][Full Text] [Related]
19. Report: workshop on mediastinal grey zone lymphoma. Poppema S; Kluiver JL; Atayar C; van den Berg A; Rosenwald A; Hummel M; Lenze D; Lammert H; Stein H; Joos S; Barth T; Dyer M; Lichter P; Klein U; Cattoretti G; Gloghini A; Tu Y; Stolovitzky GA; Califano A; Carbone A; Dalla-Favera R; Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P Eur J Haematol Suppl; 2005 Jul; (66):45-52. PubMed ID: 16007868 [TBL] [Abstract][Full Text] [Related]
20. Characterization of DLBCL with a PMBL gene expression signature. Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]